Literature DB >> 11562264

Polyphenolic compounds: interactions with the gut and implications for human health.

J M Gee1, I T Johnson.   

Abstract

Polyphenolic compounds are abundant throughout the plant kingdom and are found in a wide variety of human foods. The flavonoids, which are the best defined group of polyphenols in the human diet, themselves comprise a large and complex group, all of which contain a three-ring structure with two aromatic centres and a central oxygenated heterocycle. Recent evidence suggests that significant quantities of quercetin and possibly myricetin and kaempferol are absorbed in the gut. A larger fraction probably remains in the lumen, and thus a substantial proportion of the gastrointestinal mucosa is exposed to biologically significant concentrations of these compounds. A substantial body of experimental work has established that flavonoids can suppress carcinogenesis in animal models and there is considerable interest in the biological effects of these compounds at the cellular level. Flavonoids interact with cellular signal pathways controlling the cell cycle, differentiation and apoptosis. Their potentially antineoplastic effects include antioxidant activity, induction of Phase II enzyme activity, inhibition of protein kinases and interactions with Type II estrogen binding sites. Naturally occurring polyphenolic compounds may play a role in the protective effects of fruits and vegetables against cancers in general, and they appear to have considerable potential for pharmaceutical uses as chemopreventive agents against neoplastic changes in the alimentary tract. Future research should therefore focus on the biological effects of flavonoids in the human body, using biomarkers to define their effects at each stage in the onset of neoplasia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11562264     DOI: 10.2174/0929867013372256

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  11 in total

Review 1.  Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation.

Authors:  Anastasia I Petra; Smaro Panagiotidou; Erifili Hatziagelaki; Julia M Stewart; Pio Conti; Theoharis C Theoharides
Journal:  Clin Ther       Date:  2015-05-01       Impact factor: 3.393

2.  Metabolic and pharmacological properties of rutin, a dietary quercetin glycoside, for treatment of inflammatory bowel disease.

Authors:  Heejung Kim; Hyesik Kong; Boim Choi; Youngwook Yang; Youngmi Kim; Mi Jung Lim; Len Neckers; Yunjin Jung
Journal:  Pharm Res       Date:  2005-08-24       Impact factor: 4.200

3.  A novel approach to the synthesis of 6-amino-7-hydroxy-flavone.

Authors:  Lijun Tang; Shufen Zhang; Jinzong Yang; Wentao Gao; Jian Cui; Tianyu Zhuang
Journal:  Molecules       Date:  2004-09-30       Impact factor: 4.411

Review 4.  Polyphenols and gastrointestinal diseases.

Authors:  Gerald W Dryden; Ming Song; Craig McClain
Journal:  Curr Opin Gastroenterol       Date:  2006-03       Impact factor: 3.287

5.  Intestinal apolipoprotein B secretion is inhibited by the flavonoid quercetin: potential role of microsomal triglyceride transfer protein and diacylglycerol acyltransferase.

Authors:  Adele Casaschi; Qi Wang; Ka'ohimanu Dang; Alison Richards; Andre Theriault
Journal:  Lipids       Date:  2002-07       Impact factor: 1.880

6.  Quercetin induces apoptosis of Trypanosoma brucei gambiense and decreases the proinflammatory response of human macrophages.

Authors:  Maria Mamani-Matsuda; Jérôme Rambert; Denis Malvy; Hélène Lejoly-Boisseau; Sylvie Daulouède; Denis Thiolat; Sara Coves; Pierrette Courtois; Philippe Vincendeau; M Djavad Mossalayi
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

7.  Antioxidant activity of polyphenolic myricetin in vitro cell- free and cell-based systems.

Authors:  Abolfazl Barzegar
Journal:  Mol Biol Res Commun       Date:  2016-06

8.  In Vitro Antioxidant Properties of Dichloromethanolic Leaf Extract of Gnidia glauca (Fresen) as a Promising Antiobesity Drug.

Authors:  Wycliffe Arika; Cromwell Mwiti Kibiti; Joan Murugi Njagi; Mathew Piero Ngugi
Journal:  J Evid Based Integr Med       Date:  2019 Jan-Dec

9.  The Effect of High-Fat Diet-Induced Pathophysiological Changes in the Gut on Obesity: What Should be the Ideal Treatment?

Authors:  Chooi Y Lee
Journal:  Clin Transl Gastroenterol       Date:  2013-07-11       Impact factor: 4.488

Review 10.  Gut microbiota, probiotics and diabetes.

Authors:  Aline Corado Gomes; Allain Amador Bueno; Rávila Graziany Machado de Souza; João Felipe Mota
Journal:  Nutr J       Date:  2014-06-17       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.